Oxidopamine

Oxidopamine

Names
Preferred IUPAC name 5-(2-Aminoethyl)benzene-1,2,4-triol
Identifiers
CAS Number	1199-18-4 Y
3D model (JSmol)	Interactive image
ChEBI	CHEBI:78741 Y
ChEMBL	ChEMBL337702 Y
ChemSpider	4463 Y
ECHA InfoCard	100.013.493
EC Number	214-842-3
KEGG	D05294 Y
PubChem CID	4624
UNII	8HW4YBZ748 N
CompTox Dashboard (EPA)	DTXSID0036768
InChI InChI=1S/C8H11NO3/c9-2-1-5-3-7(11)8(12)4-6(5)10/h3-4,10-12H,1-2,9H2 Y Key: DIVDFFZHCJEHGG-UHFFFAOYSA-N Y InChI=1/C8H11NO3/c9-2-1-5-3-7(11)8(12)4-6(5)10/h3-4,10-12H,1-2,9H2 Key: DIVDFFZHCJEHGG-UHFFFAOYAG
SMILES c1c(c(cc(c1O)O)O)CCN
Properties
Chemical formula	C8H11NO3
Molar mass	169.18 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

Oxidopamine, also known as 6-hydroxydopamine (6-OHDA) or 2,4,5-trihydroxyphenethylamine, is a synthetic monoaminergic neurotoxin used by researchers to selectively destroy dopaminergic and noradrenergic neurons in the brain.

The main use for oxidopamine in scientific research is to induce Parkinsonism in laboratory animals by lesioning the dopaminergic neurons of the substantia nigra pars compacta, in order to develop and test new medicines and treatments for Parkinson's disease.